News summary

Sequoia and Greenoaks lead massive $5BN Series C funding round in Isomorphic Labs

Source: Tech.eu • Published: 17 Nov 2026, 13:07

Summarized by Masters of Longevity from Tech.eu.

Isomorphic Labs secured $5 billion to expand its AI-driven drug design platform.

Sequoia and Greenoaks lead massive $5BN Series C funding round in Isomorphic Labs
Key Takeaways
  • Funding will build foundational biology models and tools.
  • Funds will expand clinical development infrastructure and capacity.
  • Private financing is not proof of proven human efficacy.
Read the full article at Tech.eu ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.MoL PickReducing Inflammation from Ageing Cells: What a Mouse Study FoundResearchers reduced the inflammatory signals released by cells that had stopped dividing. Older mice also improved on some strength and frailty tests. Whether this approach could help people remains unknown.